Valuation Jaguar Health, Inc.

Equities

Market Closed - Nasdaq Other stock markets 02:30:00 07/02/2026 am IST			5-day change	1st Jan Change
0.6700 ^USD	+13.12%		-0.68%	-28.05%

16/01	Jaguar Health Inc - Co & unit entered license agreement with Woodward Specialty LLC - SEC filing	RE
06/01	Jaguar Health, Inc. announced that it has received $0.35 million in funding	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	85.54	47.85	13.14	7.684	11.92	3.04	3.04	-
Change	-	-44.06%	-72.54%	-41.52%	55.07%	-74.49%	0%	-
Enterprise Value (EV) ¹	85.54	47.85	13.14	7.684	11.92	-1.962	-2.551	-1.749
Change	-	-44.06%	-72.54%	-41.52%	55.07%	-116.47%	-30.02%	31.44%
P/E ratio	-0.81x	-0.88x	-0.18x	-0.08x	-0.19x	-0.07x	-1.18x	-1.68x
PBR	-	-	-	-	-	0.39x	0.46x	0.4x
PEG	-	0x	0x	0x	0x	0x	0x	0.1x
Capitalization / Revenue	9.11x	11x	1.1x	-	1.02x	0.24x	0.09x	0.11x
EV / Revenue	9.11x	11x	1.1x	-	1.02x	-0.16x	-0.07x	-0.06x
EV / EBITDA	-	-	-	-	-	0.08x	-0.91x	-0.68x
EV / EBIT	-3.21x	-1.18x	-0.38x	-	-0.39x	0.08x	-2.81x	-2.52x
EV / FCF	-	-	-	-	-	0.09x	-2.02x	14x
FCF Yield	-	-	-	-	-	1,138%	-49.4%	7.15%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-3,37,500	-1,32,750	-54,270	-2,685	-130.7	-10.11	-0.57	-0.4
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	9.385	4.335	11.96	-	11.69	12.56	34.86	28.18
EBITDA ¹	-	-	-	-	-	-23.65	2.802	2.585
EBIT ¹	-26.65	-40.71	-34.42	-	-30.83	-25.55	0.909	0.694
Net income ¹	-38.65	-52.6	-47.45	-41.3	-38.49	-29.79	-3.231	-2.346
Net Debt ¹	-	-	-	-	-	-5.002	-5.591	-4.789
Reference price ²	2,75,059.0618	1,16,999.8538	9,776.2378	227.0995	25.2500	0.6700	0.6700	0.6700
Nbr of stocks (in thousands)	0.31	0.41	1.34	33.8	472	4,537	4,537	-
Announcement Date	31/03/21	11/03/22	24/03/23	01/04/24	31/03/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
JAGUAR HEALTH, INC.	-0.07x	-0.16x	0.08x	-	30.4L
ELI LILLY AND COMPANY	46.93x	15.27x	33.84x	0.55%	95TCr
JOHNSON & JOHNSON	21.8x	6.43x	17.86x	2.15%	58TCr
ABBVIE INC.	62.39x	7.4x	18.34x	2.93%	39TCr
ROCHE HOLDING AG	18.44x	4.63x	11.48x	2.82%	37TCr
MERCK & CO., INC.	15.75x	5.05x	11.01x	2.65%	30TCr
ASTRAZENECA PLC	30.26x	5.44x	16.24x	1.69%	30TCr
NOVARTIS AG	20.34x	5.75x	14.03x	2.98%	30TCr
NOVO NORDISK A/S	13.96x	4.82x	10.24x	3.65%	21TCr
AMGEN INC.	29.86x	6.92x	11.85x	2.49%	21TCr
Average	25.97x	6.16x	14.50x	2.43%	35.97TCr
Weighted average by Cap.	32.61x	8.36x	19.66x	2.06%